N-(furan-2-ylmethyl)-1-phenylpropan-2-amine, 98%, 1g

5-(4-chlorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 100mg

2-(o-tolyl)-1,3,2-dioxaborinane, 98+%, 1g

1,3-Bis-(2,4,6-trimethyl-phenyl)-4,5-dihydro-3H-imidazol-1-ium tetrafluoro borate, 95.0%, 10g

(4-((Cyclopropylmethyl)carbamoyl)phenyl)boronic acid, 98%, 1g

2-Bromo-5-cyanopyrazine, 95.0%, 10g

iScope IS.1158-EPLi Biocular with E-plan IOS objectives and Rackless cross table (infinity - ergonomic tilting head)

1-[2-(Trimethylsilyl)ethoxycarbonyloxy]benzotriazole>98.0%(HPLC)5g

3-Bromo-6-mercaptopyridine, 98.0%, 100mg

5-Bromo-2-methoxy-4-(trifluoromethyl)pyridine, 97%, 5g

2-Chloro-N-[5-(dimethylamino)-2-nitrophenyl]-5-nitrobenzamide, 95.0%, 100mg

4-Benzyloxyfluorobenzene, 95.0%, 1g

(1S,3R)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid, 95.0%, 250mg